✦ LIBER ✦

Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach

✍ Scribed by T Lehr; A Staab; C Tillmann; E Ø Nielsen; D Trommeshauser; H G Schaefer; C Kloft

Book ID: 110009810
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 276 KB
Volume: 153
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bjp.0707539

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pharmacokinetic/pharmacodynamic/recept

A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of the benzodiazepines

✍ Jack, M.L.; Colburn, W.A.; Spirt, N.M.; Bautz, G.; Zanko, M.; Horst, W.D.; O'Bri 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 532 KB

Pharmacokinetics of ezlopitant, a novel

Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptor antagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites

✍ Anne E. Reed-Hagen; Megumi Tsuchiya; Kaoru Shimada; Jo-Ann Wentland; R. Scott Ob 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 1 views

Population Pharmacokinetic Model for a N

Population Pharmacokinetic Model for a Novel Oral Hypoglycemic Formed In Vivo: Comparing the Use of Active Metabolite Data Alone Versus Using Data of Upstream and Downstream Metabolites

✍ Kastrissios, Helen; Walker, Joseph R.; Carrothers, Timothy J.; Kshirsagar, Smita 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 904 KB

A pharmacokinetic/pharmacodynamic approa

A pharmacokinetic/pharmacodynamic approach for the comparison of penciclovir and acyclovir: Utilization of an in vitro model which simulates in vivo pharmacokinetics: F. M. Hamzeh*, H. J. Schaad, P. S. Lietman. Division of Clinical Pharmacology, The Johns Hopkins School of Medicine, Baltimore, Maryland USA

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 84 KB

The greater in vivo antiplatelet effects

The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite

✍ A. SUGIDACHI; T. OGAWA; A. KURIHARA; K. HAGIHARA; J.A. JAKUBOWSKI; M. HASHIMOTO; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

Yeast as a model eukaryote in toxinology

Yeast as a model eukaryote in toxinology: A functional genomics approach to studying the molecular basis of action of pharmacologically active molecules

✍ Mojca Mattiazzi; Uroš Petrovič; Igor Križaj 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 493 KB